Literature DB >> 29995652

Expression of HPV-induced DNA Damage Repair Factors Correlates With CIN Progression.

Chelsey C Spriggs1, Luis Z Blanco, Kruti P Maniar, Laimonis A Laimins.   

Abstract

Human papillomaviruses (HPVs) are DNA viruses with epithelial tropism. High-risk types of HPV are the causative agents of the majority of cervical cancers and are responsible for a number of other anogenital as well as oropharyngeal cancers. The life cycle of HPV is closely linked to the differentiation state of its host cell and is dependent on the activation of specific pathways of the DNA damage response. Several proteins from the ataxia telangiectasia mutated and the ataxia telangiectasia mutated and Rad3-related DNA repair pathways, which are essential for maintaining genomic stability in cells, are upregulated in HPV-positive cells and are required for viral replication. Our studies examine the expression of 5 such DNA repair factors-pCHK2, pCHK1, FANCD2, BRCA1, and H2AX-in cervical specimens from patients diagnosed with low-grade, intermediate-grade, or high-grade lesions. The percentage of cells expressing pCHK2, pCHK1, FANCD2, and BRCA1 is significantly higher in high-grade squamous intraepithelial lesions compared with that of either low-grade squamous intraepithelial lesions or normal tissue, particularly in differentiated cell layers. In addition, the distribution of this staining throughout the epithelium is altered with increasing lesion grade. This study characterizes the expression of pCHK2, pCHK1, FANCD2, H2AX and BRCA1 during cervical cancer progression and provides additional insight into the role of these DNA damage response proteins in viral transformation.

Entities:  

Mesh:

Year:  2019        PMID: 29995652      PMCID: PMC6295252          DOI: 10.1097/PGP.0000000000000477

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  28 in total

1.  Different DNA damage and cell cycle checkpoint control in low- and high-risk human papillomavirus infections of the vulva.

Authors:  Lindy A M Santegoets; Romy van Baars; Annelinde Terlou; Claudia Heijmans-Antonissen; Sigrid M A Swagemakers; Peter J van der Spek; Patricia C Ewing; Marc van Beurden; Willem I van der Meijden; Theo J M Helmerhorst; Leen J Blok
Journal:  Int J Cancer       Date:  2011-08-30       Impact factor: 7.396

Review 2.  Human papillomavirus oncoproteins: pathways to transformation.

Authors:  Cary A Moody; Laimonis A Laimins
Journal:  Nat Rev Cancer       Date:  2010-07-01       Impact factor: 60.716

Review 3.  Genomic instability and cancer: networks involved in response to DNA damage.

Authors:  Jorunn Erla Eyfjord; Sigridur Klara Bodvarsdottir
Journal:  Mutat Res       Date:  2005-07-05       Impact factor: 2.433

4.  Homologous Recombination Repair Factors Rad51 and BRCA1 Are Necessary for Productive Replication of Human Papillomavirus 31.

Authors:  William H Chappell; Dipendra Gautam; Suzan T Ok; Bryan A Johnson; Daniel C Anacker; Cary A Moody
Journal:  J Virol       Date:  2015-12-23       Impact factor: 5.103

5.  Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation.

Authors:  J Y Ahn; J K Schwarz; H Piwnica-Worms; C E Canman
Journal:  Cancer Res       Date:  2000-11-01       Impact factor: 12.701

6.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

Review 7.  HPV-related squamous neoplasia of the lower anogenital tract: an update and review of recent guidelines.

Authors:  Kruti P Maniar; Ritu Nayar
Journal:  Adv Anat Pathol       Date:  2014-09       Impact factor: 3.875

Review 8.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

9.  Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation.

Authors:  Cary A Moody; Laimonis A Laimins
Journal:  PLoS Pathog       Date:  2009-10-02       Impact factor: 6.823

10.  γH2Ax Expression as a Potential Biomarker Differentiating between Low and High Grade Cervical Squamous Intraepithelial Lesions (SIL) and High Risk HPV Related SIL.

Authors:  Konstantinos Leventakos; Sotirios Tsiodras; Theodore Kelesidis; Maria Kefala; Christine Kottaridi; Aris Spathis; Alina-Roxani Gouloumi; Abraham Pouliakis; Asimakis Pappas; Vasileios Sioulas; Charalambos Chrelias; Petros Karakitsos; Ioannis Panayiotides
Journal:  PLoS One       Date:  2017-01-24       Impact factor: 3.752

View more
  6 in total

1.  Activation of DNA damage repair factors in HPV positive oropharyngeal cancers.

Authors:  Takeyuki Kono; Paul Hoover; Kate Poropatich; Tatjana Paunesku; Bharat B Mittal; Sandeep Samant; Laimonis A Laimins
Journal:  Virology       Date:  2020-05-22       Impact factor: 3.616

Review 2.  Biology of HPV Mediated Carcinogenesis and Tumor Progression.

Authors:  Pippa F Cosper; Samantha Bradley; Lexi Luo; Randall J Kimple
Journal:  Semin Radiat Oncol       Date:  2021-10       Impact factor: 5.421

3.  Identification of Core Genes Involved in the Progression of Cervical Cancer Using an Integrative mRNA Analysis.

Authors:  Marina Dudea-Simon; Dan Mihu; Alexandru Irimie; Roxana Cojocneanu; Schuyler S Korban; Radu Oprean; Cornelia Braicu; Ioana Berindan-Neagoe
Journal:  Int J Mol Sci       Date:  2020-10-03       Impact factor: 5.923

Review 4.  Human Papillomavirus and Cellular Pathways: Hits and Targets.

Authors:  Alessandro Medda; Daria Duca; Susanna Chiocca
Journal:  Pathogens       Date:  2021-02-25

Review 5.  The Drivers, Mechanisms, and Consequences of Genome Instability in HPV-Driven Cancers.

Authors:  Vanessa L Porter; Marco A Marra
Journal:  Cancers (Basel)       Date:  2022-09-23       Impact factor: 6.575

Review 6.  Genomic Instability and DNA Damage Repair Pathways Induced by Human Papillomaviruses.

Authors:  Takeyuki Kono; Laimonis Laimins
Journal:  Viruses       Date:  2021-09-14       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.